Bibliographie
Vous trouverez ici des ressources bibliographiques concernant les lymphomes cutanés, y compris les publications du GFELC.
Vous pouvez aussi consulter les brèves du GFELC en utilisant le bouton ci-dessous :
Ou en savoir plus sur le livre écrit par les membres du GFELC :
Rechercher dans toutes les bibliographies :
Type de lymphome :
Publications du GFELC :
| Premier Auteur | Titre | Revue | Date | Lien Pubmed | Type d'article | Type de lymphome | Sous type de lymphome | Rédacteur |
|---|---|---|---|---|---|---|---|---|
| Scarisbrick J | The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T-cell lymphoma. | Br J Haematol | 2021 | 33095448 | revue | lymphome T | MF et apparentés + Sézary | - |
| Preillon J | Restoration of T-cell Effector Function, Depletion of Tregs, and Direct Killing of Tumor Cells: The Multiple Mechanisms of Action of a-TIGIT Antagonist Antibodies. | Mol Cancer Ther. | 2021 | 33277440 | biologique | Tous | - | |
| Habault J | PAK1-dependent anti-tumor effect of AAC-11-derived peptides on Sézary syndrome malignant CD4+ T lymphocytes. | J Invest Dermatol. | 2021 | 33745910 | biologique | lymphome T | Sézary | - |
| Geskin LJ | Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience. | Dermatol Ther (Heidelb) | 2021 | 34021485 | revue | lymphome T | MF et apparentés | - |
| Querfeld C | Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA-IIA Mycosis Fungoides. | Dermatology | 2021 | 34091453 | thérapeutique | lymphome T | MF et apparentés | - |
| Papadavid E | Multicentric EORTC retrospective study shows efficacy of Brentuximab Vedotin in Μycosis Fungoides and Sezary Syndrome patients with variable CD30 positivity. | Br J Dermatol | 2021 | 34137025 | thérapeutique | lymphome T | MF et apparentés + Sézary | - |
| Horwitz S | Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trial. | Leuk Lymphoma | 2021 | 34304674 | thérapeutique | lymphome T | MF et apparentés + Sézary | - |
| Kalmi G | Visceral leishmaniasis in patients with lymphoma: Case reports and review of the literature. | Medicine (Baltimore). | 2020 | 33157924 | revue | Tous | - | |
| Stadler R | Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT). | Eur J Cancer | 2021 | 34649647 | thérapeutique | lymphome T | MF et apparentés + Sézary | - |
| Dobos G | Exploring the role of the skin microenvironment in cutaneous T-cell lymphoma using single cell RNA-sequencing. | Eur J Cancer | 2021 | 34649652 | biologique | lymphome T | - | |
| Musiek ACM | Characterization and outcomes in patients with mogamulizumab-associated skin reactions in the MAVORIC trial. | Eur J Cancer | 2021 | 34649656 | therapeutique | lymphome T | MF et apparentés + Sézary | - |
| Kim YH | Patient characteristics of long-term responders to mogamulizumab: results from the MAVORIC study. | Eur J Cancer | 2021 | 34649658 | therapeutique | lymphome T | MF et apparentés + Sézary | - |
| Amatore F | Is mogamulizumab-induced alopecia areata associated with favorable outcomes in Sézary syndrome? | Eur J Cancer | 2021 | 34649661 | therapeutique | lymphome T | MF et apparentés + Sézary | GFELC |
| Dobos G | Quantifying response to various treatments using the revisited blood staging of mycosis fungoides and Sézary syndrome with the KIR3DL2 marker. | Eur J Cancer | 2021 | 34649664 | therapeutique | lymphome T | MF et apparentés + Sézary | - |
| Battesti G | Intravascular relapse of an extra-nodal NK/T-cell lymphoma, nasal-type, presenting as diffuse and eruptive telangiectasia. | Eur J Cancer | 2021 | 34649666 | anatomoclinique | lymphome T | NK | - |
| Assaf C | Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries. | Cancers | 2021 | 35008309 | therapeutique | lymphome T | MF et apparentés + Sézary | - |
| Hodak E | Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides ? Results from the PROCLIPI international Study. | Br J Dermatol | 2021 | 32574377 | review | lymphome T | MF et apparentés | - |
| Poglio S | Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity. | leukemia | 2021 | 33106625 | biologique | lymphome T | Sézary | - |
| Chebly A | Diagnosis and treatment of lymphomas in the era of epigenetics. | Blood Rev | 2021 | 33229141 | review | Tous | - | |
| Legrand A | Lack of clinical relevance of blood clonality in primary cutaneous marginal zone B-cell lymphoma. | Eur J Dermatol | 2021 | 33495148 | biologique | lymphome B | BMZL | - |
| Benarfa A | Vindesine dexamethasone as a therapeutic option in elderly blastic plasmacytoid dendritic cell neoplasms: a monocentric experience. | Leuk Lymphoma | 2021 | 33904349 | therapeutique | - | ||
| Chebly A | Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells. | Front Oncol | 2021 | 34765562 | biologique | lymphome T | Sézary | - |
| Olsen EA | Primary Cutaneous Lymphoma: Recommendations for Clinical Trial Design and Staging Update from the ISCL, USCLC, and EORTC. | Blood | 2022 | 34758074 | recommmandation | Tous | - | |
| Beylot-Barry M | Impact of blood involvement on efficacy and time to response with mogamulizumab in mycosis fungoides and Sézary syndrome. | JEADV | 2022 | 35993803 | therapeutique | lymphome T | Sézary | - |
| Chebly A | Exploring hTERT promoter methylation in cutaneous T-cell lymphomas. | Mol Oncol | 2022 | 33715271 | biologique | lymphome T | - | |
| Musiek ACM | Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management. | Dermatol Ther | 2022 | 34816383 | therapeutique | lymphome T | MF et apparentés + Sézary | - |
| Dobos G | Recent advances on cutaneous lymphoma epidemiology. | Presse Med | 2022 | 35026392 | review | Tous | - | |
| Vermeer MH | Flow cytometry for the assessment of blood tumour burden in cutaneous T-cell lymphoma: towards a standardised approach. | Br J Dermatol | 2022 | 35157307 | biologique | lymphome T | Sézary | - |
| Kothari R | Mycosis fungoides in pediatric population: comprehensive review on epidemiology, clinical presentation, and management. | Int J Dermatol | 2022 | 35193164 | review | lymphome T | MF et apparentés | - |
| Galadari A | Cutaneous gamma delta T-Cell lymphoma with indolent evolution: a series of five cases. | JEADV | 2022 | 35535450 | anatomoclinique | lymphome T | T γδ | GFELC |
| Pacaud A | Mogamulizumab-induced granulomatous dermatitis of the scalp: a distinct entity associated with clinical response. | JEADV | 2022 | 35648425 | therapeutique | lymphome T | MF et apparentés + Sézary | - |
| Battesti G | Granulomatous slack skin: clinical characteristics, prognosis and response to therapy. A study from the Cutaneous Lymphoma French Study Group. | Br J Dermatol | 2022 | 35661348 | anatomoclinique | lymphome T | MF et apparentés | GFELC |
| Bagot M | Long-term disease control and safety with the anti-CCR4 antibody mogamulizumab: Post-hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T-cell lymphoma. | Dermatol Ther | 2022 | 35695215 | therapeutique | lymphome T | MF et apparentés + Sézary | - |
| Bagot M | A new challenge area for cutaneous lymphomas. | Presse Med | 2022 | 35697420 | review | Tous | - | |
| Chebly A | Telomeric Repeat-Containing RNA (TERRA): A Review of the Literature and First Assessment in Cutaneous T-Cell Lymphomas. | Genes (Basel) | 2022 | 35328092 | review | lymphome T | - | |
| Bontoux C | Large cell transformation is an independent poor prognostic factor in Sézary syndrome: analysis of 117 cases. | Br J Dermatol | 2022 | 35791764 | anatomoclinique | lymphome T | Sézary | - |
| Laurent C | Cutaneous manifestations of lymphoid-variant hypereosinophilic syndrome. | Br J Dermatol | 2022 | 35862277 | review | lymphome T | - | |
| Wang L | Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study. | Br J Dermatol | 2022 | 35895386 | anatomoclinqiue | lymphome T | autres lymphomes T | GFELC |
| André R | Clinical characteristics of Mycosis fungoides palmaris et plantaris: two cases and a systematic literature review. | Eur J Dermatol | 2022 | 36065530 | review | lymphome T | MF et apparentés | - |
| Habault J | Validation of AAC-11-Derived Peptide Anti-Tumor Activity in a Single Graft Sézary Patient-Derived Xenograft Mouse Model. | Cells | 2022 | 36230895 | biologique | lymphome T | Sézary | - |
| Saad S | CD30-positive anaplastic large-cell lymphoma associated with mycosis fungoides after treatment with dupilumab. | Eur J Dermatol | 2022 | 36301751 | anatomoclinique | lymphome T | MF et apparentés + LPD CD30+ | - |
| Gros A | Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profiling. | PLoS One | 2022 | 35452489 | biologique | lymphome B | - | |
| Luherne C | A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma. | Acta Derm Venereol. | 2022 | 35758515 | biologique | lymphome T | Sézary | - |
| Prochazkova-Carlotti M | Patient-Derived Xenograft and Cell Line Models of Human Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type. | J Invest Dermatol. | 2022 | 36084691 | biologique | lymphome B | BDGC | - |
| Canu D | Changes in total skin electron beam therapy modalities for mycosis fungoides: A single-centre study. | Ann Dermatol Venereol | 2022 | 35595588 | therapeutique | lymphome T | MF et apparentés | - |
| Welfringer-Morin A | Clinical Features, Histological Characteristics, and Disease Outcomes of Mycosis Fungoides in Children and Adolescents: A Nationwide Multicentre Cohort of 46 Patients. | Dermatology | 2022 | 36349768 | review | lymphome T | MF et apparentés | GFELC |
| Peru S | Cutaneous Lymphocyte Antigen Is a Potential Therapeutic Target in Cutaneous T-Cell Lymphoma. | J Invest Dermatol. | 2022 | 35850209 | biologique | lymphome T | - | |
| Menguy S | Proliferative Tumor-Infiltrating Lymphocytes' Abundance within the Microenvironment Impacts Clinical Outcome in Cutaneous B-Cell Lymphomas. | J Invest Dermatol. | 2022 | 35970476 | biologique | lymphome B | - | |
| Ta VA | CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas | J Invest Dermatol. | 2023 | 36716922 | biologique | lymphome T | - | |
| Laurent C | Bone involvement in primary cutaneous diffuse large B-cell lymphoma, leg-type. | Clin Exp Dermatol | 2023 | 36730524 | anatomoclinique | lymphome B | BDGC | GFELC |
| de Masson A | Dermatomyositis versus mycosis fungoides: Challenges in the diagnosis of erythroderma with associated myositis | Ann Dermatol Venereol | 2023 | 36682974 | anatomoclinique | lymphome T | MF et apparentés | - |
| Lazaridou I | Toxic epidermal necrolysis possibly associated with mogamulizumab in a patient with Sézary syndrome | JEADV | 2023 | 36645855 | therapeutique | lymphome T | lymphome T | - |
| de Masson A | Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients | Blood | 2022 | 34905599 | biologique | lymphome T | MF et apparentés + Sézary | - |
| Roelens M | Mogamulizumab induces long term immune restoration and reshapes tumor heterogeneity in Sézary syndrome | Br J Dermatol | 2022 | 35041763 | biologique | lymphome T | MF et apparentés + Sézary | - |
| Sonigo G | Involvement of the CD39/CD73/adenosine pathway on T cell proliferation and NK cell-mediated ADCC in Sézary syndrome | Blood | 2022 | 35051270 | biologique | lymphome T | Sézary | - |
| Wang J | Head and neck granulomatous rash associated with mogamulizumab mimicking mycosis fungoides | Br J Dermatol | 2022 | 35083741 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Giustiniani J | CCR8 is a new therapeutic target in cutaneous T-cell lymphomas | Blood Adv | 2022 | 35201316 | biologique | lymphome T | MF et apparentés + Sézary | - |
| Kempf W | Clinical, histopathological and prognostic features of primary cutaneous acral CD8+ T-cell lymphoma and other dermal CD8+ cutaneous lymphoproliferations - Results of an EORTC Cutaneous Lymphoma Group Workshop | Br J Dermatol | 2022 | 34988968 | anatomo-clinique | lymphome T | CD8 | - |
| Leupin N | Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma | Cancer | 2022 | 34726773 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Menguy S | Impact of algorithms proposed by the Cutaneous Lymphoma French Study Group for diagnosis of cutaneous lymphoproliferations | Ann Pathol | 2021 | 33926757 | anatomo-clinique | Tous | Tous | GFELC |
| Algarni A | Mogamulizumab-induced vitiligo in patients with Sézary syndrome: three cases | Eur J Dermatol | 2021 | 33814357 | anatomo-clinique | lymphome T | Sézary | - |
| Porcu P | Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma | Clin Lymphoma Myeloma Leuk | 33158772 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - | |
| Levy R | Efficacy of ruxolitinib in subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis | Blood Adv | 2020 | 32271897 | anatomo-clinique | lymphome T | Panniculite | - |
| Olsen E | Primary Cutaneous Lymphoma: Recommendations for Clinical Trial Design and Staging Update from the ISCL, USCLC, and EORTC | Blood | 2021 | 34758074 | recommandation | Tous | Tous | - |
| Maeda Y | Depletion of central memory CD8 + T cells might impede the antitumor therapeutic effect of Mogamulizumab | Nat Commun | 2021 | 34907192 | biologique | lymphome T | MF et apparentés + Sézary | - |
| Zimmermann C | Diagnostic performance of high-throughput sequencing of the T-cell receptor beta gene for the diagnosis of cutaneous T-cell lymphoma | Br J Dermatol | 2021 | 33942285 | biologique | lymphome T | MF et apparentés + Sézary + LPD CD30+ + Panniculite + PCSMLPD + Tγδ + NK + CD8 + Autres lymphome T | - |
| Bergqvist C | Lymphomatoid papulosis types D and E: a multicentre series of the French Cutaneous Lymphomas Study Group | Clin Exp Dermatol | 2021 | 33987864 | anatomo-clinique | lymphome T | LPD CD30+ | GFELC |
| Moins-Teisserenc H | CD158k is a reliable marker for diagnosis of Sézary syndrome and reveals an unprecedented heterogeneity of circulating malignant cells | J Invest Dermatol | 2015 | 25158034 | biologique | lymphome T | Sézary | - |
| Skayem C | Lymph node and visceral progression without erythroderma or blood worsening in erythrodermic cutaneous T-cell lymphoma: nine cases | Br J Dermatol | 2021 | 34128541 | anatomo-clinique | lymphome T | Sézary | GFELC |
| Hodak E | Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study | Br J Dermatol | 2021 | 32574377 | recommandation | lymphome T | MF et apparentés | - |
| Fréchet L | Primary cutaneous lymphoma: a population-based cancer registry descriptive study of 155 consecutive cases diagnosed between 1979 and 2016 | Leuk Lymphoma | 2021 | 33682600 | anatomo-clinique | Tous | Tous | - |
| Kim E | The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma | Am J Clin Dermatol | 2021 | 33656660 | anatomo-clinique | lymphome T | MF et apparentés | - |
| Legrand A | Lack of clinical relevance of blood clonality in primary cutaneous marginal zone B-cell lymphoma | Eur J Dermatol | 2021 | 33495148 | anatomo-clinique | lymphome B | BMZL | - |
| Severson KJ | Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study | J Am Acad Dermatol | 2021 | 33493572 | anatomo-clinique | lymphome T | MF et apparentés | - |
| Vadivel CK | JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL) | Cancers (Basel) | 2021 | 33466582 | biologique | lymphome T | MF et apparentés + Sézary | - |
| Calvani J | Image-guided lymph node core-needle biopsy predicts survival in mycosis fungoides and Sézary syndrome | Br J Dermatol | 2021 | 33400272 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Lewis DJ | Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome | JAMA Dermatol | 2020 | 33377934 | anatomo-clinique | lymphome T | Sézary | - |
| Weiner DM | The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Current and future approaches | J Am Acad Dermatol | 2020 | 33352268 | revue | lymphome T | MF et apparentés + Sézary | - |
| Newman NB | Prospective observational trial of low-dose skin electron beam therapy in mycosis fungoides using a rotational technique | J Am Acad Dermatol | 2020 | 33333150 | anatomo-clinique | lymphome T | MF et apparentés | - |
| Charli-Joseph Y | Association of a Proposed New Staging System for Folliculotropic Mycosis Fungoides With Prognostic Variables in a US Cohort | JAMA Dermatol | 2020 | 33295938 | anatomo-clinique | lymphome T | MF et apparentés | - |
| Harkins CP | Cutaneous T-Cell Lymphoma Skin Microbiome Is Characterized by Shifts in Certain Commensal Bacteria but not Viruses when Compared with Healthy Controls | J Invest Dermatol | 2020 | 33212154 | biologique | lymphome T | MF et apparentés + Sézary | - |
| Argyropoulos KV | Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features | Blood Cancer J | 2020 | 33168809 | biologique | lymphome T | MF et apparentés + Sézary | - |
| Quaglino P | Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome | J Invest Dermatol | 2020 | 33162051 | revue | lymphome T | MF et apparentés + Sézary | - |
| Dobos G | Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry | Br J Dermatol | 2020 | 33131055 | anatomo-clinique | Tous | Tous | GFELC |
| Durgin JS | Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular Analysis | JAMA Dermatol | 2020 | 33112366 | anatomo-clinique | lymphome T | Sézary | - |
| Amatore F | ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells | Blood Adv | 2020 | 33095875 | biologique | lymphome T | MF et apparentés + Sézary | GFELC |
| Dobos G | Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 Patients | Cancers (Basel) | 2020 | 33050643 | anatomo-clinique | Tous | Tous | - |
| Dumont M | Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas | Cancers (Basel) | 2020 | 33023002 | revue | lymphome T | MF et apparentés + Sézary | - |
| Kempf W | Primary cutaneous peripheral T-cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico-pathological and prognostic features | J Eur Acad Dermatol Venereol | 2020 | 32997839 | anatomo-clinique | lymphome T | autres lymphome T | - |
| Dobos G | The value of five blood markers in differentiating mycosis fungoides and Sézary syndrome: a validation cohort | Br J Dermatol | 2020 | 33314029 | anatomo-clinique | lymphome T | Sézary | - |
| D'Incan M | Locoregional nodal extension does not impair prognosis of primary cutaneous anaplastic lymphomas | Br J Dermatol | 2020 | 32810288 | anatomo-clinique | lymphome T | LPD CD30+ | - |
| Vitiello P | Primary Cutaneous B-Cell Lymphomas: An Update. | Front Oncol | 2020 | 32528871 | revue | lymphome B | BMZL + BCFL + BDGC + intravasc | - |
| Dummer R | Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study | Eur J Cancer | 2020 | 32502876 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Quaglino P | Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study) | Br J Dermatol | 2020 | 32479678 | anatomo-clinique | lymphome T | MF et apparentés | - |
| Gaydosik AM | Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma | Blood | 2020 | 32438399 | biologique | lymphome T | MF et apparentés + Sézary | - |
| Papadavid E | Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines | J Eur Acad Dermatol Venereol | 2020 | 32416629 | recommandation | Tous | Tous | - |
| Dangien A | Ifosfamide and etoposide in advanced-stage, relapsed or refractory primary cutaneous T-cell lymphomas | Br J Dermatol | 2020 | 32407544 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Mehta-Shah N | NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020 | J Natl Compr Canc Netw | 2020 | 32380458 | recommandation | lymphome T | MF et apparentés + Sézary | - |
| Nikolaou V | Monotherapy and combination therapy with acitretin for mycosis fungoides: results of a retrospective, multicenter study | J Eur Acad Dermatol Venereol. | 2020 | 32364303 | anatomo-clinique | lymphome T | MF et apparentés | - |
| Blümel E | Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma. | Oncoimmunology | 2020 | 32363124 | biologique | lymphome T | MF et apparentés + Sézary | - |
| Salava A | Skin microbiome in cutaneous T cell lymphoma by 16S and whole genome shotgun sequencing | J Invest Dermatol | 2020 | 32353450 | biologique | lymphome T | MF et apparentés + Sézary | - |
| Lewis DJ | Mogamulizumab in the treatment of advanced mycosis fungoides and Sézary syndrome: safety and efficacy | Expert Rev Anticancer Ther | 2020 | 32320304 | revue | lymphome T | MF et apparentés + Sézary | - |
| Zic JA | Recommendations for Treatment of Cutaneous Lymphomas During the COVID-19 Pandemic. | J Am Acad Dermatol | 2020 | 32305443 | recommandation | Tous | Tous | - |
| Papadaki M | Cutaneous T-cell lymphoma: aetiopathogenesis and current diagnostic and therapeutic developments | Eur J Dermatol | 2020 | 32301713 | revue | lymphome T | MF et apparentés + Sézary | - |
| Beltzung F | Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study Group. | Am J Surg Pathol | 2020 | 32271188 | anatomo-clinique | lymphome T | PCSMLPD | GFELC |
| Maurus K | Recurrent Oncogenic JAK and STAT Alterations in Cutaneous CD30-Positive Lymphoproliferative Disorders | J Invest Dermatol | 2020 | 32147503 | biologique | lymphome T | LPD CD30+ | - |
| Moczko A | Sensitivity and specificity of T-cell receptor PCR BIOMED-2 clonality analysis for the diagnosis of cutaneous T-cell lymphoma | Eur J Dermatol | 2020 | 32250251 | biologique | lymphome T | MF et apparentés + Sézary | - |
| Yu X | Involvement of p53 acetylation in growth suppression of Cutaneous T-cell lymphomas induced by HDAC inhibition | J Invest Dermatol | 2020 | 32119867 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Kim EJ | Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study | J Am Acad Dermatol | 2020 | 32089294 | anatomo-clinique | lymphome T | MF et apparentés | - |
| Walia R | An Update on Molecular Biology of Cutaneous T Cell Lymphoma | Front Oncol | 2020 | 32039026 | revue | lymphome T | MF et apparentés | - |
| Bontoux C | Outcome and clinicophenotypical features of acute lymphoblastic leukemia/lymphoblastic lymphoma with cutaneous involvement: A multicenter case series. | J Am Acad Dermatol | 2020 | 32007515 | anatomo-clinique | lymphome T | autres lymphome T | GFELC |
| Song A | A prospective cohort study of condensed low-dose total skin electron beam therapy for mycosis fungoides: Reduction of disease burden and improvement in quality of life. | J Am Acad Dermatol | 2020 | 32004646 | anatomo-clinique | lymphome T | MF et apparentés | - |
| Wu X | A Small Molecule CCR2 Antagonist Depletes Tumor Macrophages and Synergizes with Anti-PD-1 in a Murine Model of Cutaneous T-Cell Lymphoma (CTCL) | J Invest Dermatol | 2020 | 31945344 | biologique | lymphome T | MF et apparentés + Sézary | - |
| Clough L | Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of Georgia | Cancer | 2020 | 31943154 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Vu K | Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study | Clin Cancer Res | 2020 | 31772119 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Menguy S | Challenges in Assessing MYC Rearrangement in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type. | Am J Surg Pathol | 2020 | 31764222 | biologique | lymphome B | BDGC | - |
| Melchers RC | Frequency and prognosis of associated malignancies in 504 patients with lymphomatoid papulosis | J Eur Acad Dermatol Venereol | 2020 | 31715046 | anatomo-clinique | lymphome T | LPD CD30+ | - |
| Bresin A | Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell Lymphoma. | J Invest Dermatol | 2020 | 31682844 | biologique | lymphome T | MF et apparentés + Sézary | - |
| Shimony S | Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study. | Hematol Oncol | 2019 | 31674027 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Ferranti M | Immunomodulation in Cutaneous T Cell Lymphoma | Front Oncol | 2019 | 31649883 | revue | lymphome T | MF et apparentés + Sézary + LPD CD30+ | - |
| O'Malley JT | Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides. | Clin Cancer Res | 2020 | 31636100 | anatomo-clinique | lymphome T | MF et apparentés | - |
| Murga-Zamalloa C | Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability. | Clin Cancer Res | 2020 | 31636099 | biologique | lymphome T | MF et apparentés + Sézary | - |
| Tanita K | Bexarotene Reduces Production of CCL22 From Tumor-Associated Macrophages in Cutaneous T-Cell Lymphoma | Front Oncol | 2019 | 31616630 | biologique | lymphome T | MF et apparentés + Sézary | - |
| Fernández-de-Misa R | Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma | J Eur Acad Dermatol Venereol | 2020 | 31591786 | anatomo-clinique | lymphome T | LPD CD30+ | - |
| Ritchie S | Evaluation of haematopoietic stem cell transplantation in patients diagnosed with cutaneous T-cell lymphoma at a tertiary care centre: should we avoid chemotherapy in conditioning regimes? | Br J Dermatol | 2020 | 31536644 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Engelina S | Brentuximab a novel antibody therapy: real-world use confirms efficacy and tolerability for CD30-positive cutaneous lymphoma. | Br J Dermatol | 2020 | 31529492 | anatomo-clinique | lymphome T | MF et apparentés + Sézary + LPD CD30+ | - |
| Iyer A | Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma | Blood | 2019 | 31515249 | biologique | lymphome T | MF et apparentés + Sézary | - |
| Geller S | Outcomes and prognostic factors in African American and black patients with mycosis fungoides/Sézary syndrome: Retrospective analysis of 157 patients from a referral cancer center | J Am Acad Dermatol | 2019 | 31499157 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Knobler R | European dermatology forum - updated guidelines on the use of extracorporeal photopheresis 2020 | J Eur Acad Dermatol Venereol | 2020 | 33025659 | recommandation | lymphome T | MF et apparentés + Sézary | - |
| Gilson D | British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018 | Br J Dermatol | 2019 | 30561020 | recommandation | Tous | Tous | - |
| Battistella M | Primary Cutaneous Follicular Helper T-cell Lymphoma: A New Subtype of Cutaneous T-cell Lymphoma Reported in a Series of 5 Cases. | Arch Dermatol | 2012 | 22508770 | anatomo-clinique | lymphome T | autres lymphome T | - |
| Blom A | Lymphoma-associated hemophagocytic syndrome in advanced-stage mycosis fungoides/Sézary syndrome cutaneous T-cell lymphoma. | J Am Acad Dermatol | 2011 | 21550694 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Beylot-Barry M | Lymphomes T cutanés : recommandations de prise en charge. | Ann Dermatol Venereol | 2011 | 21703465 | anatomo-clinique | lymphome T | - | |
| Caudron A | Two atypical cases of cutaneous gamma/delta T-cell lymphomas. | Dermatology | 2011 | 21606639 | anatomo-clinique | lymphome T | Tγδ | - |
| Oberholzer PA | Extra-nodal non-Hodgkin-lymphoma with an acneiform eruption: folliculotropic mycosis fungoides. | Eur J Haematol | 2011 | 21554402 | anatomo-clinique | lymphome T | MF et apparentés | - |
| Laharanne E | Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes. | J Invest Dermatol | 2010 | 20130593 | biologique | lymphome T | Tous | - |
| Laharanne E | CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma. | Mod pathol | 2010 | 20118908 | biologique | lymphome T | Tous | - |
| Pham-Ledard A | IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases. | J Invest Dermatol | 2010 | 19812605 | biologique | lymphome T | LPD CD30+ | - |
| Beylot-Barry M | Prise en charge des lymphomes T cutanés : recommandations du Groupe Français d’étude des Lymphomes Cutanés. | Ann Dermatol Venereol | 2010 | 20932440 | recommandation | lymphome T | GFELC | |
| Parmentier L | Specific Nail Alterations in Cutaneous T-Cell Lymphoma: Successful Treatment With Topical Mechlorethamine. | Arch Dermatol | 2010 | 21079067 | anatomo-clinique | lymphome T | - | |
| Jidar K | Gemcitabine treatment in cutaneous T-cell lymphoma: a multicentre study of 23 cases. | Br J Dermatol | 2009 | 19438862 | anatomo-clinique | lymphome T | - | |
| Leinweber B | Solitary small- to medium-sized pleomorphic T-cell nodules of undetermined significance: clinical, histopathological, immunohistochemical and molecular analysis of 26 cases. | Arch Dermatol | 2009 | 19349695 | anatomo-clinique | lymphome T | PCSMLPD | - |
| Beltraminelli H | Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases. | Am J Dermatopathol | 2009 | 19461234 | anatomo-clinique | lymphome T | PCSMLPD | - |
| Beltraminelli H | Indolent CD8+ lymphoid proliferation of the ear: A phenotypic variant of the small-medium pleomorphic cutaneous lymphoma? | J Cut Pathol | 2009 | 19602068 | anatomo-clinique | lymphome T | CD8 | - |
| Quereux G | Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with advanced or refractory mycosis fungoides or Sézary syndrome. | Arch Dermatol | 2008 | 18559761 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Marty M | Primary cutaneous T-cell lymphomas do not show specific NAV3 gene deletion or translocation. | J Invest Dermatol | 2008 | 18509363 | biologique | lymphome T | - | |
| Pham-Ledard A | MYD88 Somatic Mutation is a genetic feature of primary cutaneous diffuse large B-cell lymphoma, Leg-type. | J Invest Dermatol | 2012 | 22495176 | biologique | lymphome B | BDGC | - |
| Lipowicz S | Bone involvement in two cases of thoracic primary cutaneous diffuse large B-cell lymphoma, leg type. | Eur J Dermatol | 2011 | 21700538 | anatomo-clinique | lymphome B | BDGC | - |
| Pham-Ledard A | IRF4 expression without IRF4 rearrangement is a general feature of primary cutaneous diffuse large B-cell lymphoma, leg type. | J Invest Dermatol | 2010 | 20054341 | biologique | lymphome B | BDGC | - |
| Grange F | Prise en charge des lymphomes B cutanés : recommandations du Groupe Français d’étude des Lymphomes Cutanés. | Ann Dermatol Venereol | 2010 | 20804896 | recommandation | lymphome B | GFELC | |
| Guyot A | Combined treatment with Rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients. | Arch Dermatol | 2010 | 20083704 | anatomo-clinique | lymphome B | BDGC | - |
| Grange F | Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab. | Arch Dermatol | 2009 | 19289772 | anatomo-clinique | lymphome B | BDGC | - |
| Belaud-Rotureau MA | Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas. | Virchows Arch | 2008 | 18311490 | biologique | lymphome B | BDGC | - |
| Vitte F | Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations. A study of 42 cases. | Am J Surg Pathol | 2012 | 22895265 | anatomo-clinique | autre article | Non applicable | GFELC |
| Bénet C | Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases. | Am J Clin Pathol | 2011 | 21228369 | anatomo-clinique | autre article | Non applicable | GFELC |
| Dalle S | Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? | Br J Dermatol | 2010 | 19689477 | anatomo-clinique | autre article | Non applicable | - |
| Pham-Ledard A | Disseminated cutaneous lymphoid hyperplasia of 12 years' duration triggered by vaccination. | Dermatology | 2010 | 20029164 | anatomo-clinique | autre article | Non applicable | - |
| Cornejo MG | Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models. | Blood | 2009 | 19139084 | biologique | autre article | Non applicable | - |
| Pham-Ledard A | Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma. | Mod Pathol | 2014 | 24030746 | biologique | lymphome B | BDGC | - |
| Grange F | Improvement of Survival in Patients With Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, in France. | JAMA Dermatol | 2014 | 24647650 | anatomo-clinique | lymphome B | BDGC | GFELC |
| Pham-Ledard A | High Frequency and Clinical Prognostic Value of MYD88 L265P Mutation in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type. | JAMA Dermatol | 2014 | 25055137 | anatomo-clinique | lymphome B | BDGC | - |
| Bertolotti A | Lymphomatoid papulosis type D: an aggressive histology for an indolent disease. | Br J Dermatol | 2013 | 23746266 | anatomo-clinique | lymphome T | LPD CD30+ | - |
| Jullié ML | CD20 antigen may be expressed by reactive or lymphomatous cells of transformed mycosis fungoides: diagnostic and prognostic impact. | Am J Surg Pathol | 2013 | 24145652 | anatomo-clinique | lymphome T | MF et apparentés | - |
| Michel L | Use of PLS3, Twist, CD158k/KIR3DL2, and NKp46 gene expression combination for reliable Sézary syndrome diagnosis. | Blood | 2013 | 23429988 | biologique | lymphome T | Sézary | - |
| Schneider P | NKp46-specific expression on skin-resident CD4(+) lymphocytes in mycosis fungoides and Sézary syndrome. | J Invest Dermatol | 2014 | 23900021 | biologique | lymphome T | MF et apparentés + Sézary | - |
| de Masson A | Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas. | Haematologica | 2014 | 24213148 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | GFELC |
| Chevret E | Telomerase functions beyond telomere maintenance in primary cutaneous T-cell lymphoma. | Blood | 2014 | 24470590 | biologique | lymphome T | - | |
| Robson A | Aggressive Epidermotropic Cutaneous CD8+ Lymphoma: A cutaneous lymphoma with distinct clinical and pathological features Report of an EORTC Cutaneous Lymphoma Task Force Workshop. | Histopathology | 2014 | 24438036 | anatomo-clinique | lymphome T | CD8 | - |
| de Masson A | Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T-cell lymphomas. | Br J Dermatol | 2014 | 24438061 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Couronné L | STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model. | Haematologica | 2013 | 23872306 | biologique | autre article | Non applicable | - |
| Ingen-Housz-Oro S | HIV-related CD8+ cutaneous pseudolymphoma: efficacy of methotrexate. | Dermatology | 2013 | 23343593 | anatomo-clinique | autre article | CD8 | - |
| Julia F | Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. | Br J Dermatol | 2013 | 23646868 | anatomo-clinique | autre article | Non applicable | GFELC |
| Knobler R | Guidelines on the use of extracorporeal photopheresis. | J Eur Acad Dermatol Venereol | 2014 | 24354653 | anatomo-clinique | Lymphome T | MF et apparentés + Sézary | - |
| Julia F | Blastic Plasmacytoid Dendritic Cell Neoplasms: Clinico-immunohistochemical Correlations in a Series of 91 Patients. | Am J Surg Pathol | 2014 | 24441662 | anatomo-clinique | autre article | Non applicable | GFELC |
| Bertolotti A | Two cases of proliferation of monoclonal and monotypic lymphocytes and plasma cells corresponding to acrodermatitis chronica atrophicans. | Ann Dermatol Venereol | 2014 | 24951145 | anatomo-clinique | autre article | Non applicable | - |
| Ingen-Housz-Oro S | Folliculotropic T-cell infiltrates associated with B-cell chronic lymphocytic leukaemia or MALT lymphoma may reveal either true mycosis fungoides or pseudolymphomatous reaction: seven cases and review of the literature. | J Eur Acad Dermatol Venereol | 2015 | 24646004 | anatomo-clinique | autre article | Non applicable | GFELC |
| Laban E | Lymphoproliférations cutanées : propositiond’algorithmes diagnostiques à partir de l’expérience sur 2 ans des réseaux INCa (LYMPHOPATH et GFELC) sur 2760 lymphoproliférations cutanées. | Annales de Pathologie | 2015 | 25778761 | anatomo-clinique | autre article | Non applicable | GFELC |
| Ingen-Housz-Oro S | Immediate hypersensitivity reaction to pegylated liposomal doxorubicin: management and outcome in four patients. | Eur J Dermatol | 2016 | 28524061 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Menguy S | PD-L1 and PD-L2 Are Differentially Expressed by Macrophages or Tumor Cells in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type. | Am J Surg Pathol | 2018 | 29112015 | biologique | lymphome B | BDGC | - |
| Menguy S | Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas. | Mod Pathol | 2018 | 29581544 | biologique | lymphome B | BDGC | - |
| Gauci ML | Outcomes of radiation therapy of indolent cutaneous B-cell lymphomas and literature review. | J Eur Acad Dermatol Venereol | 2018 | 29578630 | anatomo-clinique | lymphome B | - | |
| Beylot-Barry M | A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg Type. | J Invest Dermatol | 2018 | 29596904 | anatomo-clinique | lymphome B | BDGC | GFELC |
| de Masson A | Alopecic patches of the scalp: a variant of primary cutaneous follicle centre B-cell lymphoma reported in a series of 14 cases. | J Eur Acad Dermatol Venereol | 2019 | 30716178 | anatomo-clinique | lymphome B | MF et apparentés | - |
| Dangien A | Clinical presentation, therapeutic approach and outcome of primary cutaneous marginal zone B-cell lymphoma presenting as AL amyloidoma of the skin. | Br J Dermatol | 2019 | 30801660 | anatomo-clinique | lymphome B | BMZL | - |
| Blaizot R | Infectious events and associated risk factors in mycosis fungoides/Sézary syndrome: a retrospective cohort study. | Br J Dermatol | 2018 | 30098016 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Visseaux L | T-cell papulosis associated with B-cell malignancy: a distinctive clinicopathologic entity. | J Eur Acad Dermatol Venereol | 2018 | 29356170 | anatomo-clinique | autre article | Non applicable | GFELC |
| Daragon C | Biphasic pathological pattern in transformed mycosis fungoides not associated with DUSP22-IRF4 translocation. | Histopathology | 2019 | 30457169 | anatomo-clinique | lymphome T | MF et apparentés | - |
| Scarisbrick JJ | Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force. | Eur J Cancer | 2018 | 29477101 | recommandation | lymphome T | MF et apparentés + Sézary | - |
| Hurabielle C | KIR3DL2 expression in patients with adult T-cell lymphoma/leukaemia. | Br J Dermatol | 2018 | 29315492 | anatomo-clinique | lymphome T | autres lymphome T | - |
| Scarisbrick JJ | Developments in the understanding of blood involvement and stage in mycosis fungoides/Sezary syndrome. | Eur J Cancer | 2018 | 30017383 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Egal A | Palliative Radiotherapy for Disfiguring Mycosis Fungoides Lesion: A Key Treatment to Reduce Psychological and Social Impact. | Rep Dermatol Med | 2018 | 30147966 | anatomo-clinique | lymphome T | MF et apparentés | - |
| Fertitta L | Folliculotropic Mycosis fungoides associated with GATA2 deficiency: a new skin manifestation. | Br J Dermatol | 2018 | 30101490 | anatomo-clinique | lymphome T | MF et apparentés | - |
| Kim YH | Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. | Lancet Oncol | 2018 | 30100375 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| de Masson A | Folliculotropic CD8+ mycosis fungoides associated with diffuse mucosal involvement. | JAAD Case Rep | 2018 | 30246124 | anatomo-clinique | lymphome T | MF et apparentés | - |
| Quaglino P | Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium. | Ann Oncol | 2019 | 28961843 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Mahévas T | Dramatic response to brentuximab vedotin in a refractory non-transformed CD30-negative mycosis fungoides allowing allogeneic stem cells transplantation and long-term complete remission. | Br J Dermatol | 2019 | 30269331 | anatomo-clinique | lymphome T | MF et apparentés | - |
| Dequidt L | Cutaneous lymphomas appearing during treatment with biologics: 44 cases from the French Study Group on Cutaneous Lymphomas and French Pharmacovigilance Database. | Br J Dermatol | 2019 | 30835817 | anatomo-clinique | Tous | GFELC | |
| Olsen E | Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). | Blood | 2007 | 17540844 | anatomo-clinique | lymphome T | MF et apparentés + Sézary | - |
| Willemze R | The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. | Blood | 2019 | 30635287 | Tous | Tous | - |
Cet ouvrage collectif est le premier réalisé par le Groupe français d’études des lymphomes cutanés (GFELC), groupe multidisciplinaire francophone qui émet des avis de recours pour la prise en charge des lymphomes cutanés.
